The Center of Excellence for Interventional Medicine for Precise and Advanced Cellular Therapy (IMPACT), in collaboration with the South & Central America Regional Executive Committee of the ISCT, International Society for Cell & Gene Therapy, together with Clínica Universidad de los Andes, and Mayo Clinic, is thrilled to announce the upcoming IMPACT CGT Meeting 2024.
This symposium is a unique convergence of cell, gene therapy, and immunotherapy innovation, bringing together a global community of scientists, clinicians, and industry experts.
Why Attend?
Engage with cutting-edge developments in Immunotherapy, including CAR-T, NK Cells, TReg, point-of-care manufacturing, and clinical site qualification.
Explore advances in Stem Cell-Based Therapies like EVS, modified MSCs, and tissue engineering.
Who Should Attend?
Scientists and researchers in cell and gene therapy.
Clinicians and healthcare professionals in immunotherapy and stem cell therapy.
Industry experts and stakeholders in biomedicine.
Confirmed Speakers Include:
- Dr. Bruce Levine, PhD in Immunology and Infectious Diseases, Johns Hopkins.
- Dr. Jonás Paludo, Hematologist, Internist, and Oncologist, Mayo Clinic.
- Dr. Julián Molina, Hematologist and Oncologist, Mayo Clinic.
- Dr. Arkadiusz Dudek is an oncologist and expert in cellular and acellular therapy at Mayo Clinic.
- PhD Patrick Hanley, ISCT North America Regional Vice-President.
- PhD Martin Bonamino, Researcher at Instituto Nacional del Cancer (INCA), Brazil.
- PhD Cristina Puig, Adjunct Assistant Professor, Department of Medicine, UCLA Health.